Andreas Maderna
AstraZeneca (United States)(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Boron Compounds in Chemistry, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography
Most-Cited Works
- → Applications of Radiolabeled Boron Clusters to the Diagnosis and Treatment of Cancer(1999)513 cited
- → Tumor Cells Chronically Treated with a Trastuzumab–Maytansinoid Antibody–Drug Conjugate Develop Varied Resistance Mechanisms but Respond to Alternate Treatments(2015)259 cited
- → RDEA119/BAY 869766: A Potent, Selective, Allosteric Inhibitor of MEK1/2 for the Treatment of Cancer(2009)183 cited
- → Discovery of Cytotoxic Dolastatin 10 Analogues with N-Terminal Modifications(2014)131 cited
- → A Camouflagednido-Carborane Anion: Facile Synthesis of Octa-B-methyl-1,2-dicarba-closo-dodecaborane(12) and Its Deboration Reaction(1999)101 cited
- → Synthesis, Molecular Editing, and Biological Assessment of the Potent Cytotoxin Leiodermatolide(2014)93 cited
- → Recent Advances in the Development of New Auristatins: Structural Modifications and Application in Antibody Drug Conjugates(2015)93 cited
- → Total Syntheses and Biological Reassessment of Lactimidomycin, Isomigrastatin and Congener Glutarimide Antibiotics(2013)91 cited
- → Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis(2011)63 cited
- → Syntheses, Structures, and Reactivity of Hexaborylbenzene Derivatives(2000)63 cited